Vol. 170, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATiONS
July 31, 1990
Pages 433-440
DIFFERENCES
IN COMPOSITION
AND FLUIDITY
MEMBRANE VESICLES David
Received
June
PREPARED BY DIFFERENT
J. Bjorkman
VAMC and University
OF INTESTINAL
of Utah
and Earl
Medical
J.
MICROVILLUS
METHODS
Brigham
Center,
Salt
Lake
City,
Utah
9, 1990
Multiple methods have been developed to isolate the intestinal microvillus membrane and facilitate the study of its composition and function. Variations in membrane composition and fluidity may result from different preparative techniques. This study shows that the use of MgClz and/or KSCN in vesicle preparation alters phospholipid and protein composition of the membrane compared to CaCl, precipitation. The use of MgCl, in membrane preparation increased phosphatidylethanolamine and decreased phosphatidylinositol content. The use of KSCN in membrane preparation decreased the protein content. The structural changes seen with the use MgClz alone are accompanied by an increase in both static and dynamic membrane fluidity. These results suggest that different methods of membrane vesicle preparation affect membrane phospholipid and protein content as well as membrane fluidity. al990 Academic Press, Inc.
Intestinal
epithelial
and basolateral of specific Membrane
function techniques
commonly
apical
10]
depends
and separated as if
were
density there
may vary
enzymes
salts but
electron
change
in does
membrane
the
the
lipid
ABBREVIATIONS MVM, Microvillus 12-AS, DL-12-(q-anthroyl)stearic
vesicle
has
shown
the
or protein which
is
that
the
membrane; acid.
by
of
[11,12].
particle
suggesting
that
[12,15].
of membrane
vesicles
complex
lipid-protein
may
1,3,5-hexatriene;
OOO6-291x/90 433
MVM
Freeze
intramembrane
1,6-diphenyl
been
The use
enrichment
and distribution
composition
DPH,
have
and function and phospholipid
technique,
content determined
methods
structure
the
Most
Ca++ or Mg'+ [8-
proteins
preparative
protein
components. [2-123.
[5,6,10-12,141.
increases
cytoskeletal
also
with
of its
structure
technique
apical the site
absorption.
membranes cations
membrane
preparation
in membrane in
that
defined (MVM) is
nutrient
Different
to study
so by extracting
fluidity,
these
by divalent
preparative
well
relationships
centrifugation.
membrane
vary
to normal
to isolate
however,
microscopy
differences
Alterations
structural
are precipitated
with
with membrane
critical
interchangeable,
and distribution are
the
Evidenceexists,
thiocyanate
fracture
upon
polarized
microvillus
systems
by differential
they
composition marker
are highly
The apical
have been developed membranes
[2,3,5,12.13]. of
[l].
enzyme and transport
Numerous
used,
cells
domains
$1.50
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
170,
No.
2, 1990
BIOCHEMICAL
AND
BIOPHYSICAL
interactions. Changes in membrane fluidity membrane function [16]. The present study composition prepared
and demonstrates by different
differences
RESEARCH
COMMUNICATIONS
may have significant identifies changes
in membrane fluidity
effects on in membrane
in MVM vesicles
methods. MATERIALS AND METHODS
ANIMALS Adult male Sprague-Dawley rats weighing 225 to 300 grams (Bantin and Animals were fasted overnight Kingman, Fremont CA) were used in all studies. and anesthetized with intraperitoneal sodium pentobarbital. MICROVILLUS MEMBRANEVESICLES Microvillus membrane vesicles were prepared at 4. C by four different Two groups were prepared by standard previously described methods [8-12,173. divalent cation precipitation and two groups using additional thiocyanate The method using CaCl, with differential centrifugation was modified treatment. Alternatively, MgC& from the method of Schmitz and colleagues [8]. Both CaC12 and MgC& precipitation was used as described by Hauser [lo]. precipitated vesicles were additionally purified using KSCN by the method of Hopfer [11]. VESICLE ENRICHMENT was evaluated for membrane purity by Each preparation of vesicles determining the enrichment of the apical membrane enzymes sucrase and alkaline Protein was determined by the method of Bradford [18] using a phosphatase. Sucrase activity was measured by the commercial kit (Bio-Rad, Richmond, CA). method of Messer and Dahlqvist [19] as modified by Grand et al. [20]. Alkaline phosphatase activity was determined by the method of Bessey et al. [21]. Na+/K+ATPase activity was assessed by the method of Scharschmidt et al. [22]. Mean enrichment of sucrase was 16.8-fold for CaC&. 18.5 for MgCl,, 34.9 Alkaline for CaCl, with KSCN and 28.9 for MgCl, with KSCN prepared vesicles. phosphatase enrichment was 10.6 for CaC12. 13.6 for the MgCl,, 20.0 for the CaCl, with KSCN and 22.3 for the MgCl, with KSCN preparations. Basolateral membrane contamination was minimal in all groups, as determined by decreased Na'/K'ATPase activity. Electron microscopic evaluation of vesicle pellets from each group was similar to that published previously [12]. There was no microscopic evidence of contaminating membrane populations, LIPID ANALYSIS Membrane lipids were extracted from MVM vesicles by chloroform:methanol extraction [23]. Cholesterol content was determined enzymatically [24] using a commercial kit (Sigma Chemical Co., St. Louis, MO). Phospholipid composition was determined by two-dimensional thin layer chromatography of plates coated with silicagelH [25]. Chloroform-methanol-28% ammoniumhydroxide (65:25:5) was used in first the system and chloroform-acetone-methanol-acetic acid-water (3:4:1:1:0.5) was used in the second system. Individual phospholipid content was determined from gel scrapings using a modification of the method of Bartlett
L.261. MEMBRANEFLUIDITY MEASUREMENT Static and dynamic fluidity of MVM vesicles was estimated by measuring steady state fluorescence anisotropy using the method of Schachter and Shinitxky 1,3,5-hexatriene (DPH) and DL-12-(9-anthroyl) stearic acid C27]. 1,6-diphenyl (12-AS) were used as probes. Steady state fluorescence anisotropy (r) was measured immediately at 24. C using a SLM 4800 fluorometer (SLM Instruments, Inc., Urbana IL) with an excitation wavelength of 360 nm for DMH and 365 nm for 12-AS. Emission above 397 nm was measured using cut-off filters. Fluorescence anisotropy was calculated according to the equation r=(I I )/ (I +21 ) [28]. Corrections for light scattering and ambient fluorescence were made using vesicle suspensions without probe and by pelleting membrane
434
Vol.
170, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
from the medium. Excited state lifetimes were determined for each probe using both phase shift and frequency modulation methods at 6 MHz and 18 MHz. Lifetime measurements did not vary significantly between vesicle preparations for either probe, suggesting that differences in anisotropy were not due to differenti.al probe quenching or other probe related factors.
vesicles
STATISTICAL ANALYSIS Statistical significance of all data was determined using a two-tailed Student's t-test for independent samples. RESULTS PHOSPHOLIPIDANDCHOLESTEROL COMPOSITION The phospholipid composition profile is shown in figure 1. MgCl;, precipitation with or without KSCN treatment significantly increasedvesiclemembranephosphatidylethanolamine with CaCl,, precipitation. Vesicle preparation
The use of (p
comparedtovesiclesprepared with MgCl* alone decreased
membranephosphatidylinositol content compared to other groups (~(0.05). There was a slight increase in lysophosphatidylcholine in the vesicles prepared with CaClz alone,
but
lysophospholipids vesicle
group.
this
did
not
achieve
statistical
comprised less than 2% of the total Treatment with KSCNdid not Alter
significance. lipid
Other
phosphorus of any
the phospholipid
composition
of the membranevesicles.
PC
cl CaCl, Figure
1.
LPC
SPHINGO
PE
q NCb
PS
q Ca/KSCN
PI
FFA
LPL
q Mg/KSCN
Phospholipid composition determined by two dimensional thin layer Values are chromatography of MVM prepared by different methods. expressed as the percent of total lipid phosphorus f the standard PC=phosphatidylcholine. error of the mean (n=ll for all values). LPC=lysophosphatidylcholine, SPH=sphingomyelin, PE=phosphatidylethanolamine. PS=phosphatidylserine, PI=phosphatidylinositol. FFA= free fatty acids, LPL= less polar lipids. Lysophosphatidylethanolamine represented less than 2% of each group. *PE was higher in each magnesium treated group (pcO.01). **PI in the MgCl, group was lower than all other groups (pcO.05).
435
Vol.
170,
No.
BIOCHEMICAL
2, 1990
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
40 x
30
T
I
10
CaC1,
q )CHOLESTEROL:PROTEIN Figure
CaCl,
Treatment
with
prepared
vesicles
(figure
KSCN increased
This
group
f
0.016
but lipid
not
groups
(17.95
* 3.29
CaCl,
precipitation
ratio
alone value
(7.57
and 15.87 * 0.95)
(10.8
* 1.89)
0.277
with
was not
0.030 in
the with
to the CaCl,
MgC12 (p>O.O5).
was also
(p
f
in
when treated
when compared
* 3.52
that
to
(ug/mg)
had an increase
* 0.038
significant prepared
SRM)
also
to 0.305
the vesicles calcium
ratio
f
@Cl,
* 0.029
phosphorus:protein with
(mean
with
was statistically
(p
increased
in KSCN treated
with
magnesium)
MgCl,
precipitation
statistically
compared
to
resulted different
from
group.
The cholesterol:total betweenvesicle with
PHOSPHORUS:PAOTEIN
cholesterol:protein
prepared
from 0.216
difference
in an intermediate
the
0.157
Vesicles ratio
The total
any other
from
2).
cholesterol:protein KSCN.
q
Mg/KSCN
TOTAL LIPID
Cholesterol:protein (ug/mg x 10) and total lipid phosphorus:protein ratio for MVMprepared by different techniques. Values are expressed as the ratio f the standard error of the mean (n=ll for all values). 'Increased the cholesterol:protein ratio compared to CaCl, treatment alone (p
2.
(p
CalKSCN
MU,
respect
lipid
groups, to total
be responsible
for
our
noted
previously
phosphorus
ratio
suggestingthatcholesterol phospholipids
the other
and that
ratio
extraction
did
not
vary
composition
changes.
differences These
of cytoskeletal
in protein
findings
proteins
significantly
remains are
unchanged content
consistent
may with
by KSCN [12].
FLUORESCENCE ANISOTROPY Fluorescence lower
in
anisotropy.
membrane
groups
(p
dynamic
membrane
in
determinedbyboth
vesicles all fluidity
prepared
cases, are
table
using 1).
increased 436
DPH and12-AS MgCl 2 alone
This
indicates
in this
group.
was significantly
compared that
both
to
all static
other and
Vol. 170, No. 2, 1990
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS TABLE 1
FLUORESCENCEANISOTROPY OF MICROVILLUS MEMBRANE PREPARATIONS
Preparative
Fluorescence
Group
DPH
Anisotropy
(r) Q-AS
CaC12
0.276
f 0.001
0.135
f 0.002
MgCL
0.267
t 0.002~
0.129
* 0.002,
CaCl, + KSCN
0.277
i 0.002
0.139
f 0.002
MgCla + KSCN
0.278
f 0.003
0.139
f 0.002
Fluorescence anisotropy (r) determined by steady state fluorescence polarization using DPH and 12-AS as probes in microvillus membrane vesicles prepared by different methods. Values are r value f SFM. * p
DISCUSSION These the
data
suggest
prepar.ative
with
an increased
vesicles. noted
These
role
thiocyanate
are
extracts
are
cases, consistent
studies True
our
previous
changes
for
[Zq].
remained
profile
of intramembrane
MgCl,
seen with
by the extraction
showing
the protein
with
ratios
ratio results
who also
in view of the broad
messenger
can be accounted
and distribution
membrane within
difficult
to achieve membrane
the
lipid
different
fluorescence
polarization
types
A variety
"fluidity". been
the
that
of
unchanged.
KSCN treatment
on SDS-PAGE analysis
particles
used
fluidity
to estimate of
freedom
An exact
bilayer.
because
have overall
describes
"fluidity"
limitations, estimating
with
prepared
Mg+' precipitation
decreased
significance
cholesterol:phospholipid
vesicles
and colleagues, is
with
seen in freeze
[12].
molecules overall
membrane
with
as a second
vary
to calcium
and phospholipid:protein
proteins,
the number
fracture
of Aubry content
of the vesicles
cytoskeletal
and alters
to those
may be of particular
the
provides compared
phosphatidylethanolamine
cholesterol:protein
.In all data
precipitation
phosphatidylinositol This
and composition
content
similar
membrane
treatment
protein.
structure
of phosphotidylinositol
The higher
These
in
alone.
physiologic
Magnesium
results
Additionally,
precipitation
MVM vesicle
phosphatidylethanolamine
an i,ncrease
t-141.
that
technique.
of molecular of
techniques,
membrane
membrane
probes
[14,27,28,30-331. 437
of
motion
determination
order has been Because
of of
motion each
is
contribute
to
having
C27.281. widely of
membrane
fluidity
their
its
Steady
own state
accepted rotational
for
Vol.
170,
No.
2, 1990
characteristics AS are
and localization
often
fluidity
used
to
static is
and dynamic to
simultanteous phosphatidylinositol change
in
membrane
presence
or absence
exposure
in
vivo
in
one
it A
factor.
and decrease unlikely that
is
change
acid
in
length
in the
phospholipid and saturation,
in
be noted
that
vesicles
studies
irreversibly
a variety
and fatty
were
technique addition
calcium
to calcium
exposure
these
the
MVM by at
composition
calcium
through
that
in vitro
vivo
precipitation that
by
intestinal
in phospholipid
suggest
of membrane
have shown of
of vesicles
while
same MgClz
together
may be affected
fluidity
exposure
[38],
should
the
a
fluidity the
an alteration
by
[28,35-373,
any
It
and colleagues
Direct
It
to
in fatty
vesicle
Brasitus
fluidity
through
the fluidity
solely
may decrease
mechanisms.
studies
to
Because
methods.
of influences
fluidity
a higher
changes.
of calcium.
prepared
in
due
membrane
[38,x9].
These
affect
observed
decrease
vesicles
membrane
have
by other
a variety
increase
is
or in vitro
fluidity
study.
of
precipitation
prepared
of
such as changes
that
two different
saturation
DPH and 12-
components
in membrane phosphatidylethanolaine seen with Mg+' precipitation.
the
exists
MgCl,
vesicles
this
factors,
in
may reversibly
COMMUNICATIONS
of the membrane
and dynamic with
result
fluidity
Other
decreases
the
attribute
a role
RESEARCH
depths
static
prepared than
is
is
Evidence
least
the
fluidity
increase
composition. may play
acid
estimate
fluidity
difficult
BIOPHYSICAL
in different
MVM vesicles
membrane
AND
[28,34].
respectively Intestinal
net
BIOCHEMICAL
performed
used or
in
this
depletion
of direct
may
and indirect
mechanisms. It of
has been established
membrane
have
that
the
vesicle
regarding is likely system.
vesicles
that
are
fracture
analysis
activates
membrane
Neither
this
increase
in
study
groups
that
all
We have [12].
differ
from
MgC12
precipitation
CaCl,
phosphatidylinositol
although
content
intestinal
Aubry
alter
Meddings
the
in
and
colleagues axis
between
composition
this
a variety
crypt-villus
of the relationship study
introduce that
is
membrane
and
may have at least
CaCl,
fluidity important
changes
on freeze that [14]
provides
tissue fracture CaCl,
lysophospholipid
and colleagues
some artifact
preparation
intestinal
have suggested
and increases with
on freeze with
content noted
MgClz
precipitation [lo].
a significant
the use of calcium.
the mechanisms
increases
the
to intact
have noted
of
preparations
example,
shown
and colleagues that
For
methods
similar
phospholipases
may directly
functions.
previously
Others
nor
noted
membrane
structurally
fluidity
function,
preparative
lysophospholipids
In summary,
Because and
various
[ 153. Hauser
preparation
along
[ho]. fluidity
between
implications It
transport
fluidity
structure,
differences
into
glucose
to membrane
composition,
membrane
[16,30.31,38,39].
functions
shown
related
that
in membrane
are not
clear,
composition,
structure
phosphatidylethanolaine and increases
438
static
prepared
MgCl>
and fluidity.
content, and dynamic
vesicles
membrane
decreases fluidity.
Vol.
The
170,
No.
use
of
differences
2, 1990
BIOCHEMICAL
KSCN alters should
membrane
be considered
AND
BIOPHYSICAL
structure in
studies
and using
RESEARCH
protein
COMMUNICATIONS
composition.
These
MVM vesicles.
ACKNOWLEDGMENTS This project and a Biomedical
was supported by the Veterans Administration Research Support Grant from the University
Research of Utah.
Service
REFERENCES 1.
;:
4. 5. 6. 7. 8. 9. 10. 11. 12.
13. 14.
Madara, J. L. and Trier, J. S. of the (1987) in Physiology Gastrointestinal Tract, 2nd ed. (Johnson L.R., ed.), pp. 1209-1250, Raven, New York. Murer, H. and Kinne, R. (1980) J. Membrane Biol. 55, 81-95. Hopfer, U. 233, E445-449. (1977) Am. J. Physiol. Eicholz, A. and Crane, R. K. (1965) J. Cell. Biol. 26, 687-691. Semenza. G., Kessler, M.. Hosang, M., Wever, J. and Schmidt, U. (1984) Biochim. Biophys. Acta 779, 343-379. Steiger, B. and Murer, H. (1983) Eur. J. Biochem. 135, 95-101. K. and Bro, B. (1982) Biochim. Biophys. Acta Carlsen, J., Christiansen, 689, 12-20. Schmitz, J.. Preiser, H., Maestracci, D., Ghosh, B. K.. Cerda, J. J. and Crane, R. K. (1973) Biochim. Biophys. Acta 323, 98-112. Kessler, M., Acute, O., Storelli, C., Murer, H., Muller, M. and Semenza, Bhichim. Biophys. Acta 506, 136-154. G. (1978) Haussr, H., Howell, K., Dawson, R. M. C. and Bowyer, D. E. (1980) Biochim. Bioplhys. Acta 602. 567-577. Hopfler U., Crowe, T. D. and Tandler, B. (1983) Anal. Biochem. 131, 447452. Bjorlkman, D. J.. Allan, C. H., Hagen, S. J. and Trier, J. S. (1986) Gastroenterology 91, 1401-1414. (1985) J. Pediatr. Gastroenterol. Nutr. 4, 865-867. Hopfler U. Aubr,y, H., Merril, A. R. and Proulx, P. (1986) Biochim. Biophys. Acta 856.
610-8614.
15. 16. 17. 18.
19.
20. 21.
22.
23.
G. C. and Patton, J. S. (1985) Biochim. Biophys. Riglfer, W. W., Ferreira, Acta 816, 131-141. Brasitus, T. A., Schachter, D. (1980) Biochemistry 19, 2763-2769. Peerce, B. E. and Wright, E. M. (1984) Proc. Natl. Acad. Sci. USA 81, 2223-2226. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254. Dahlqvist, A. (1968) Anal. Biochem. 22. 99-107. Grand, R. J.. Chong, D. A. and Isselbacher, K. J. (1972) Biochim. Biophys. Acta 261. 341-352. (1946) J. Biol. Chem. 164, Bessey, 0. A., Lowry, 0. H. and Brock. M. J. 321-329. Scharschmidt, B. F., Keefe, E. B., Blankenship, N. M. and Ockner, R. K. (1979) J. Lab. Clin. Med. 93, 790-799. Folch, J., Lees, M. and Stanley, G. H. S. (1957) J. Biol. Chem. 226, 497-
509.
24. 25.
26. 27. 28. 29. 30.
Allain, C. A., Poon, L. S. and Ghan. C. S. G. et al. 20. 470-475. A. and Nelson, D. H. Murray, D. K.. Ruhmann-Wennhold,
(1974) Clin. (1979)
Chem.
Endocrinology
105, 774-777.
(1959) J. Biol. Chem. 234, 466-468. Bartlett, G. R. Invest. 59. Schacter. D. and Shinitzky, M. (1977) J. Clin. Schachter, D. (1984) Hepatology 4, 140-151. Hokin, L. E. (1985) Ann. Rev. Biochem. 54, 205-235. Brasitus, T. A., Schachter, D. and Manouneas, T. G. (1979) 18, 4136-4144. 439
536-548. Biochemistry
Vol.
170,
No.
2, 1990
BIOCHEMICAL
A.,
A. R. and Schachter,
RESEARCH
D.
COMMUNICATIONS
(1980) Biochemistry
Brasitus,
32. 33.
Van Blitterswijk, W. J., Van Hoeven, R. P. and Van Der Meer, B. W. Biochim. Biophys. Acta 644, 322-332. Hauser. H., Gains, N., Semenza, G. and Spiess, M. (1982) Biochemistry
34.
Brasitus,
;2:
Shinitzky, Ladbrooke, Shinitzky,
38. 39.
Brasitus T. A. Dudeja P. K., K. (1987) Am Meddings J. B.
1256-1261.
19, (1979) 21,
5621-5628. T. A.,
Dudeja,
P. K.,
Eby,
B. and Lau,
K.
(1986) J. Biol.
Chem.
35, 16404-16409. M. and Inbar, M. (1974) J. Mol. Biol. 85. 603-615. B. D. and Chapman, D. (1969) Chem. Phys. Lipids 3, 305-356. M. and Barenholz, Y. (1978) Biochim. Biophys. Acta 515, 367-
394.
40.
Tall,
BIOPHYSICAL
31.
37.
T.
AND
and Dudeja P. K. (1986) Biochem J. 239, 625-631. Brasitus T. A., Dahiya R., Brown M. D., Thomas D. and Lau J. Physiol. 252, G398-G403. and DeSouza D. (1989) Gastroenterology 96, A338.
440